17:27 EDT Acurx (ACXP) files to sell 585,000 shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP:
- Acurx granted new patent for DNA Polymerase IIIC Inhibitors
- Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?
- Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat
- Acurx’s ibezapolstat receives positive EMA opinion in C. difficile infection
- Acurx Pharmaceuticals Increases Authorized Common Stock Shares